Milan, Italy. The center specializes in the treatment and correction of orthopedic deformities due to neurological disorders of childhood and development. Thanks to the specialized and multidisciplinary approach to patient management, many children from all regions of the country are referred to our center. Procedures for implantation of the ITB system were usually performed by the same surgeon (F.M.).
In this review we included 430 children and adolescents consecutively treated with ITB from September 1998 to April 2012. Patient selection for ITB therapy is currently performed according to the treatment guidelines provided by Dan et al., 12 while patient management and clinical procedures have been standardized over the years, taking into consideration the available best practices. 4, 12 Patients selected for the ITB treatment, or their parents, signed an informed consent form and their data were registered in a database. Collected data included safety and clinical information assessed at baseline and at follow-up visits by means of validated scales specifically selected according to diagnosis, age, Gross Motor Function Classification System (GMFCS) score, 28 and functional and clinical conditions. The GMFCS is a 5-level classification system that describes gross motor function in patients with cerebral palsy on the basis of their selfinitiated movement. Distinctions between levels depend on functional abilities, the need of assistive technology including handheld mobility devices (such as walkers, crutches, or canes) or wheeled mobility, and to a much lesser extent the quality of movement. Table 1 lists the GMFCS levels with their accompanying descriptions.
To avoid any bias linked to the operator, assessments at baseline and at follow-up were performed by the same team of 2 rehabilitation therapists (including C.E.A.) and 1 orthopedic physician who followed the patients during treatment. Patients selected for the ITB implant remained hospitalized for approximately 1 week. After surgery, pa tients received minimal physical therapy; trunk rotation should be especially avoided during this time and an abdominal belt is recommended. 12 During patient hospitalization the baclofen dose was titrated to optimize treatment efficacy and minimize side effects.
Approximately 25% of patients with implants were followed at our center for each phase of the therapy. For these patients, until the optimization of baclofen titration was completed, follow-up visits included dose adjustment according to health conditions and the assessment of clinical outcomes and possible adverse events. The pump functionality was checked with the clinician programmer and, if required, the pump was also refilled. Follow-up visits were scheduled after considering the refill interval period and were performed with the same approach described above. The remaining 75% of patients found it more convenient to refill the implanted pump at other centers, and follow-up visits at our hospital were periodically scheduled at least once a year.
Surgical Procedure
All patients were implanted with SynchroMed EL or the last available model SynchroMed II programmable system (Medtronic, Inc.). The intrathecal catheter used was InDura Intrathecal Catheter (Model 8709SC), and since September 2011, the new model Ascenda Intrathecal Catheter (Model 8780-8781) has been used. The expected battery life was 3-7 years for SynchroMed EL system and 6-7 years for SynchroMed II, depending on flow rate (https://professional.medtronic.com).
During the implantation procedure, the catheter was guided along the vertebral canal up to the appropriate level for the intended therapeutic aim and was then connected to the infusion pump through an extension. 4 The procedure for pump placement was modified in March 2003. Previously, it was placed in a subcutaneous abdominal pocket, while later the pump was placed more deeply into the abdomen, under the external oblique muscle and the abdominal rectus. This new procedure was intended to minimize infection risk and pump decubitus that may occur especially in very slim children. 6, 20 In addition, to minimize infections, we also introduced a preoperative prophylaxis protocol including antibiotic administration for 48 hours, and antibacterial washing with povidoneiodine the evening before the procedure and before entering the operating room.
Significant Complications
Major complications were defined as events that required a surgical intervention to be solved and included CSF leaks, infections, and device problems related to the pump or catheter. In cases of infections, the system was usually explanted and intravenous antibiotics were administered. Cerebrospinal fluid leaks appeared as subcutaneous swelling posteriorly beneath the lumbar incision, anteriorly over and around the pump, or both, and usually developed within the first 2 weeks after surgery. 4 Usually pa tients with CSF leaks were symptom free but had visible and palpable signs (such as swelling). The symptoms usually improved with bed rest and pressure dressing. Only large accumulations around the pump, usually located in front, were treated by aspirating the fluid; if the fluid reaccumulated, a blood patch might have been indicated. The most common device problems were those related to the catheter that could leak, resulting from breakage, tearing, coiling, kinking/occlusion, or disconnection, resulting in an underdose or abrupt cessation of ITB. 13, 23, 32, 34 The pump itself could flip over in the pocket with the anterior surface faced posteriorly. If this resulted in a chronic problem, the pump was surgically secured. 22 
Data Collection and Analysis
In this study we examined data related to major complications occurring in the population with implants. The analysis included data on patients affected by events as well as the total number and details of events that occurred. Assessing infections, we compared the 2 groups of patients who received implants using either the subcutaneous or subfascial technique. The temporal distribution of events related to the catheter was also considered. Continuous data were presented as mean ± SD and differences between groups were evaluated using the Student t-test for independent samples, or the Wilcoxon rank-sum test otherwise. Categorical variables were presented as absolute, and relative frequency and differences between groups were evaluated with the Fisher exact test. A Kaplan-Meier failure curve was created to assess the temporal distribution of events. Differences between groups were evaluated by means of a log-rank test.
Results

Overall Characteristics
The study population was composed of 430 consecutive patients followed for a mean of 8.6 ± 3.8 years (range 12 months to 14 years). There were 265 males and 165 females, with a mean age at implantation of 13.3 ± 5.9 years. Table 2 lists the disease specifics of the study population. The majority of the population was affected by cerebral palsy, classified according to the GMFCS score as follows: 4.4% Level II, 12.8% Level III, 23.5% Level IV, and 59.3% Level V. Table 3 reports the technical features of implanted pumps in the assessed population. In the considered period of 14 years, 142 patients (33%) needed to replace the pump due to battery depletion, and 9 patients replaced the battery twice. In no cases was the battery life less than expected.
Overall Complications
In this analysis we considered only major complications, defined as those requiring a surgical intervention to be managed. A total of 137 major complications were recorded in 107 patients (25%). Infection occurred in 40 patients (9.3%), CSF leakage in 21 (4.9%) and catheter problems in 65 (15.1%). Pump malfunction was not common and occurred only in 4 cases (1%). Twenty-three patients (5.3%) experienced more than 1 event.
Infections. Table 4 reports the number of patients with infections in the overall population and in the 2 groups of patients classified according to pump placement (subcutaneous [n = 149] or subfascial [n = 281]). Infection occurred in 30 patients in the subcutaneous group and in 10 patients in the subfascial group. The infection rate was 20.1% in the first group and 3.6% in the latter group (p < 0.001), respectively. Figure 1 shows the cumulative probability of infections occurring in these 2 groups of patients over time. A statistically significant difference in the temporal distribution of events was found (p = 0.012).
Of the 40 patients with infection, in 30 (75%) the event led to device explantation. A total of 41 infections occurred in 40 patients: in 26 patients after the first implant and in 15 after pump replacement. Considering these 2 groups of patients, we found a rate of infection of 6% for the first implants (26/430 patients) and 10.6% for pump replacements (15/142 patients).
CSF Leakage. Twenty-one patients (4.9%) were affected by CSF leakage, treated with 1 or more venous patches. Cerebrospinal fluid leaks also occurred in 38 other patients (8.8%) but these events were not considered major complications because they cleared spontaneously without any surgery. In 3 cases chronic CSF leakage led to explantation of the system.
Catheter Problems. In 65 patients (15.1%) we recorded at least 1 event related to the catheter, such as drawing out, disconnection, or breakage. Figure 2 shows the temporal distribution of actions related to the events that occurred (mean 2.94 ± 2.75 years from implantation). These events resulted in catheter replacement in 61 patients (93.8%) while in the other 4 cases (6.2%) the event led to device explantation due to patient dissatisfaction (2 cases) or due to other associated complications (CFS leakage and pump problems).
Pump Problems. Four patients (1%) experienced an adverse event related to the implanted device that required a surgical procedure. In 3 cases the pump flipped over and in 1 case it spontaneously migrated into the intraperitoneal cavity. Two of these patients had the pump removed following an adverse event related to the device. In the other 2 patients the pump flipped but the event was resolved spontaneously without any surgery.
Device Explantations. A total of 72 patients (16.7%) underwent explantation of the pump. Of these patients, 30 (41.7%) had the pump explanted after infection, 27 (37.5%) due to patient/parental request, 3 (4.2%) after chronic CSF leakage, 2 (2.8%) due to supposed device problems, and 10 (13.9%) for reasons not well labeled. Nineteen patients (4.4%) died due to causes unrelated to the ITB therapy but related to the pathology, most commonly respiratory problems. The majority of these patients had cerebral palsy (Level V) and the mean age at death was 16.6 ± 6.4 years.
Discussion
While ITB is an effective treatment to manage spasticity of different origins, adverse events related to the device or the administered drug are known to occur and need to be managed. 23 In this study we followed 430 consecutive pediatric patients who underwent ITB system implantation in our department for the treatment of spasticity and/or dystonia. The large number of treated patients, the long followup period, and the standardization of clinical and technical procedures according to available guidelines and best practices allowed a reliable description of the adverse events that occurred, which is useful for improving knowledge on the overall results of ITB therapy. The literature reports a complication rate of 20%-30% for ITB therapy; 9, 16 this value, and the rate of each event, may be different among published works according to the features of the assessed population, the implantation technique, and the follow-up period. In our study we found that 25% of assessed patients underwent 1 or more adverse events. No neurological complications were recorded.
Infections
In the overall population, infections occurred in 9.3% of patients, consistent with other published data. 7, 8 However, this result significantly differed in the 2 groups of patients in which the pump was implanted using different techniques (subcutaneously or under the fascia) and with a different preoperative prophylaxis protocol. The subfascial position resulted in a more protected site that appeared to prevent the risk of infection and skin ulceration, usually one of the first signs of infection in very slim children. 3, 24, 32 The analysis also revealed that the higher probability of infection in the subcutaneous group, compared with the subfascial group, was maintained during the follow-up period. In addition, for the subcutane- ous group, the probability of infection increases quickly within the 1st month after implantation and then increases more slowly. In the subgroup of patients who had their pumps replaced after battery depletion, we found a higher rate of patients experiencing an infection compared to patients at the first implantation. Previously Albright et al., 4 in their study on best practice, indicated pump replacement as a factor in increasing risk of infection.
Cerebrospinal Fluid Leakage
Our surgical treatment of CSF leakage has been progressively reduced over the years; in the past we applied a venous patch, but since 2005 we have started to apply a pressure dressing that leads to spontaneous resolution of the event. Fluid aspiration was required in only a few cases.
Catheter Problems
Adverse events related to the catheter were the most frequent, and their frequency in this study was similar to data reported by other authors. 7, 9, 17 The analysis revealed that the majority of events occurred during the first 12 months after the implant, while the number of patients with a complication related to the catheter decreased in the following years. This might be explained by the fact that a certain time interval is required before the catheter is stabilized.
In our analysis we did not observe a difference in the event rate between first implants and replacements, as discussed in the literature. 4 Despite the relatively high frequency of complications related to the catheter, this event did not result in interruption of the ITB therapy except for a few cases in which it was associated with other complications. However, because the event may lead to abrupt baclofen withdrawal, which may be life-threatening and necessitate a surgical procedure, it should be avoided as much as possible. A good practice might be to perform periodic radiography during the first 2 years after pump implantation, while less frequent control imaging should be prescribed later.
Technological improvements might help to prevent adverse events: the new Ascenda intrathecal catheter has a special design aimed at improving resistance to kinking, breaks, and occlusions, and to reduce catheter dislodgement by using a new anchor tool. In our data collection, no patients with this new model reported complications, although the number of implants performed with the new catheter was small and results need to be confirmed later.
Pump Problems
Problems related to the pump were rare. Subfascial pump placement may be associated with a lower complication rate, 21 but one risk with this placement is the inadvertent and unrecognized opening of the peritoneum, in which the pump can drop into the peritoneal cavity. However, in our data collection, only 1 of these cases was recorded.
Of the 72 cases of pump explantation, 37.5% was due to patient/family requests. However, the majority of patients with implants and their families reported good satisfaction with the ITB treatment as confirmed by long follow-up periods and the desire to replace the pumps after battery depletion. This study is one of the largest singlecenter cohorts of patients who underwent pump implantation by the same surgeon with a long-term follow-up period. Some methodological limitations of the study included the retrospective analysis and that the collection was limited to major complications only (those requiring surgical procedures).
Conclusions
Meticulous technique and appropriate patient management can reduce surgical complications related to ITB pump implantation. As confirmed by the literature, the introduction of the subfascial technique leads to a dramatic reduction of infection risk. However, pump replacement may be critical and should be managed very carefully. Complications were resolved with surgical procedures, and the majority of parents and patients were satisfied with the ITB therapy.
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